PROOF-Registry New and Extended Belgium -Luxembourg
NCT03732859 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 575
Last updated 2022-02-15
Summary
A Prospective Observational Registry to describe the disease course and outcomes of Idiopathic Pulmonary Fibrosis patients in a real-world clinical setting.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
-
Roche Farma, S.A
collaborator INDUSTRY -
Belgian Thoracic Society
lead OTHER
Principal Investigators
-
Wim Wuyts, Phd, MD · Universitaire Ziekenhuizen KU Leuven
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-09
- Primary Completion
- 2021-11-01
- Completion
- 2022-01-09
Countries
- Belgium
- Luxembourg
Study Locations
More Related Trials
-
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
NCT03261037 ·Status: COMPLETED ·Phase: NA
-
Pulmonary Fibrosis Foundation Patient Registry
NCT02758808 ·Status: COMPLETED
-
Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases - EXCITING
NCT02645968 ·Status: COMPLETED
-
Database for Interstitial Lung Disease
NCT04707781 ·Status: RECRUITING
-
IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis
NCT02803580 ·Status: COMPLETED
-
Contribution of Four Pulmonary Function Tests to Diagnosis in the Primary Care.
NCT03424083 ·Status: UNKNOWN
-
Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison
NCT02076269 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
NCT00212511 ·Status: WITHDRAWN
-
Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life
NCT03420235 ·Status: COMPLETED ·Phase: NA
-
Impact of Chronic Air Pollution on Non-cystic Fibrosis Bronchiectasis
NCT01906047 ·Status: COMPLETED
-
Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary Fibrosis
NCT03744598 ·Status: TERMINATED
-
Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02128529 ·Status: COMPLETED
-
Blood Eosinophil Measurements in Patients With Chronic Obstructive Pulmonary Disease
NCT03853642 ·Status: COMPLETED
-
Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)
NCT01134822 ·Status: COMPLETED
-
Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis
NCT02594059 ·Status: COMPLETED ·Phase: NA
-
Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank
NCT02951416 ·Status: ACTIVE_NOT_RECRUITING
-
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
NCT02315586 ·Status: COMPLETED
-
To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease
NCT04430491 ·Status: COMPLETED
-
Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment
NCT05875532 ·Status: COMPLETED
-
Autonomic Function in Patients With COPD
NCT05667311 ·Status: COMPLETED
-
Nutritional Status in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT03709498 ·Status: COMPLETED
-
Systemic Consequences and Comorbidities in Mild/Moderate Chronic Obstructive Pulmonary Disease (COPD), Time for Action!
NCT01314807 ·Status: UNKNOWN
-
Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria
NCT06522334 ·Status: RECRUITING
-
Integrating Molecular, Genomic, Morphology and Environmental Features to Improve Precision Diagnosis and Treatment in Interstitial Lung Diseases (PRECISION-ILD)
NCT05998512 ·Status: RECRUITING
-
Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)
NCT02719184 ·Status: COMPLETED